Free Trial
NASDAQ:ADTX

Aditxt (ADTX) Stock Price, News & Analysis

Aditxt logo
$1.69 -0.01 (-0.59%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$1.70 +0.01 (+0.59%)
As of 07:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Aditxt Stock (NASDAQ:ADTX)

Key Stats

Today's Range
$1.66
$1.73
50-Day Range
$1.61
$7.17
52-Week Range
$1.51
$27,200.00
Volume
27,313 shs
Average Volume
786,808 shs
Market Capitalization
$3.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Aditxt Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

ADTX MarketRank™: 

Aditxt scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Aditxt.

  • Price to Book Value per Share Ratio

    Aditxt has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.14% of the float of Aditxt has been sold short.
  • Short Interest Ratio / Days to Cover

    Aditxt has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aditxt has recently increased by 0.89%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Aditxt does not currently pay a dividend.

  • Dividend Growth

    Aditxt does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.14% of the float of Aditxt has been sold short.
  • Short Interest Ratio / Days to Cover

    Aditxt has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aditxt has recently increased by 0.89%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Aditxt has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Aditxt this week, compared to 1 article on an average week.
  • Search Interest

    Only 3 people have searched for ADTX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Aditxt to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aditxt insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.01% of the stock of Aditxt is held by insiders.

  • Percentage Held by Institutions

    Only 15.54% of the stock of Aditxt is held by institutions.

  • Read more about Aditxt's insider trading history.
Receive ADTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aditxt and its competitors with MarketBeat's FREE daily newsletter.

ADTX Stock News Headlines

Missed Nvidia? Trump’s Trade War Could Create a Bigger Winner
Missed out on Nvidia? Don’t worry — a bigger AI opportunity may be emerging right now, thanks to Trump’s newly announced tariffs. One under-the-radar U.S. semiconductor stock just gained a major edge over its foreign rivals. With demand poised to skyrocket, this chipmaker could be perfectly positioned to ride the next wave of AI growth. Shares are still flying low — but not for long.
See More Headlines

ADTX Stock Analysis - Frequently Asked Questions

Aditxt's stock was trading at $47.45 at the start of the year. Since then, ADTX stock has decreased by 96.4% and is now trading at $1.69.
View the best growth stocks for 2025 here
.

Aditxt, Inc. (NASDAQ:ADTX) announced its quarterly earnings results on Thursday, May, 15th. The company reported ($8.12) EPS for the quarter, topping analysts' consensus estimates of ($26,400.00) by $26,391.88. The firm earned $0 million during the quarter, compared to analyst estimates of $0.43 million.

Shares of Aditxt reverse split on the morning of Monday, March 17th 2025. The 1-250 reverse split was announced on Wednesday, March 12th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Top institutional shareholders of Aditxt include IFP Advisors Inc (17.64%). Insiders that own company stock include Paribas Securities Corp Bnp, Financial Lp Hrt and Amro A Albanna.
View institutional ownership trends
.

Shares of ADTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aditxt investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Plug Power (PLUG), SNDL (SNDL), AMC Entertainment (AMC) and Walt Disney (DIS).

Company Calendar

Last Earnings
5/15/2025
Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ADTX
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.38 million
Pretax Margin
-30,525.09%

Debt

Sales & Book Value

Annual Sales
$55,323.00
Price / Cash Flow
N/A
Book Value
$2,687.49 per share
Price / Book
0.00

Miscellaneous

Free Float
14,233,000
Market Cap
$3.58 million
Optionable
No Data
Beta
1.60
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ADTX) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners